IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

AstraZeneca completes acquisition of Sumitomo's stake in AstraZeneca Japan

9:19 AM MDT | March 26, 2014 | Natasha Alperowicz

AstraZeneca announced today that it has completed the purchase of Sumitomo Chemical’s remaining shares in AstraZeneca K.K. (Osaka). Sumitomo announced last month that it planned to sell its 20% stake in AstraZeneca K.K. The purchase was valued at approximately ¥10 billion ($102 million) and gives AstraZeneca full control of AstraZeneca K.K.  “Our decision to gain full control of AstraZeneca K.K. reinforces our focus on Japan as a key growth platform,” says Marc Dunoyer, CEO of AstraZeneca.    Japan is the world's...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa